1. Home
  2. HRL vs KYMR Comparison

HRL vs KYMR Comparison

Compare HRL & KYMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hormel Foods Corporation

HRL

Hormel Foods Corporation

N/A

Current Price

$21.89

Market Cap

11.2B

ML Signal

N/A

Logo Kymera Therapeutics Inc.

KYMR

Kymera Therapeutics Inc.

N/A

Current Price

$132.62

Market Cap

9.0B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
HRL
KYMR
Founded
1891
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Meat/Poultry/Fish
Medicinal Chemicals and Botanical Products
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.2B
9.0B
IPO Year
1994
2020

Fundamental Metrics

Financial Performance
Metric
HRL
KYMR
Price
$21.89
$132.62
Analyst Decision
Hold
Strong Buy
Analyst Count
10
24
Target Price
$25.31
★ $144.57
AVG Volume (30 Days)
★ 4.7M
893.7K
Earning Date
12-03-2026
10-29-2026
Dividend Yield
★ 5.18%
N/A
EPS Growth
N/A
★ N/A
EPS
★ 0.72
N/A
Revenue
★ $12,106,160,000.00
$39,211,000.00
Revenue This Year
$0.07
$153.53
Revenue Next Year
$1.95
N/A
P/E Ratio
$31.60
★ N/A
Revenue Growth
★ 1.55
N/A
52 Week Low
$18.96
$58.87
52 Week High
$26.60
$136.57

Technical Indicators

Market Signals
Indicator
HRL
KYMR
Relative Strength Index (RSI) 59.31 65.27
Support Level $20.38 $104.96
Resistance Level $22.03 N/A
Average True Range (ATR) 0.47 7.07
MACD 0.22 1.97
Stochastic Oscillator 59.56 78.38

Price Performance

Historical Comparison
HRL
KYMR

About HRL Hormel Foods Corporation

Historically meat-focused, Hormel Foods broadened its lineup to include other protein offerings and became a branded food company. The firm sells its wares through multiple channels, including US retail (61.6% of fiscal 2025 sales), US foodservice (32.6%), and international (less than 6%). By product, 73% of fiscal 2025 sales were from perishable food and 27% from shelf-stable. Major brands include Hormel, Spam, Jennie-O, Columbus, Applegate, Planters, and Skippy. Many of these hold the number one or two market share in their respective categories.

About KYMR Kymera Therapeutics Inc.

Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of differentiated medicines that address health problems and meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, and IRAK4.

Share on Social Networks: